Your browser doesn't support javascript.
loading
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
Yin, Yue; Peng, Qian; Ma, Longhao; Dong, Yi; Sun, Yinan; Xu, Silu; Ding, Nianyang; Liu, Xiaolin; Zhao, Mingye; Tang, Yaqian; Mei, Zhiqing; Shao, Hanqiao; Yan, Dan; Tang, Wenxi.
Afiliação
  • Yin Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Peng Q; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China.
  • Ma L; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Dong Y; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China.
  • Sun Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Xu S; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Ding N; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Liu X; Department of Pharmacy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Zhao M; Department of Pharmacy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Tang Y; Department of Pharmacy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Mei Z; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Shao H; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China.
  • Yan D; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China.
  • Tang W; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China.
Qual Life Res ; 33(3): 753-765, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38079024
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China